Vote Scores
Filings read through

Pacira Biosciences, Inc.: how funds voted at the meeting of 10 Jun 2025

Ticker
PCRX
Meeting
Season
year to 30 June 2025
Filers reporting
388
Ballot items
5

388 filers on Form N-PX reported votes at the Pacira Biosciences, Inc. meeting of 10 Jun 2025. The records fall into 5 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2025. The latest season on file is the year to 30 June 2026. The page of Pacira Biosciences, Inc. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2025. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    3 nominees. 86.4% of the reported votes are for. 33 filers withheld from or voted against at least one nominee.

    822 vote records from 141 filers. 9 of the 140 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 40 fund families
    • For 38
    • Abstain or withhold 2
    • Against management 2
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    566 vote records from 387 filers. 223 of the 381 filers that marked the item voted against management. 6 filers gave no management mark.

    • Positions of 48 fund families
    • For 18
    • Against 30
    • Against management 30
  3. Item 3: Frequency of the say-on-pay vote

    One year: 360 filers. Three years: 7 filers. For: 5 filers. Against: 2 filers. 1-year: 2 filers. Abstain: 2 filers.

    561 vote records from 384 filers. 11 of the 376 filers that marked the item voted against management. 8 filers gave no management mark.

    • Positions of 48 fund families
    • Split or no vote 48
    • Against management 1
  4. Item 4: Audit-related items (auditor ratification)

    276 vote records from 141 filers. 5 of the 140 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 40 fund families
    • For 40
  5. Item 5: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    275 vote records from 140 filers. 75 of the 139 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 40 fund families
    • For 16
    • Against 23
    • Abstain or withhold 1
    • Against management 24

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Pacira Biosciences, Inc., meeting of 10 Jun 2025Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Pay-vote frequency4. Auditor
AllianceBernsteinAgainst, against managementSplitNo report
AllspringAgainst, against managementSplitFor
American CenturyAgainst, against managementSplitFor
BairdAgainst, against managementSplitNo report
BlackRock and iSharesAgainst, against managementSplitFor
BNY MellonForSplitFor
Brighthouse FundsForSplitFor
Charles SchwabAgainst, against managementSplitFor
Columbia ThreadneedleAgainst, against managementSplitFor
DimensionalAgainst, against managementSplit, against managementFor
DWSAgainst, against managementSplitFor
EquitableAgainst, against managementSplitFor
Federated HermesForSplitNo report
FidelityForSplitFor
First TrustAgainst, against managementSplitFor
Franklin TempletonAgainst, against managementSplitFor
Global XForSplitFor
Goldman SachsForSplitFor
Guggenheim and RydexAgainst, against managementSplitFor
Hartford FundsForSplitFor
InvescoAgainst, against managementSplitFor
J.P. MorganForSplitFor
Jackson National fundsForSplitFor
John Hancock and ManulifeAgainst, against managementSplitFor
Lincoln FinancialForSplitFor
Lord AbbettAgainst, against managementSplitNo report
MassMutualForSplitNo report
Morgan Stanley, Eaton Vance and CalvertAgainst, against managementSplitFor
NationwideAgainst, against managementSplitFor
Natixis and Loomis SaylesForSplitNo report
Neuberger BermanForSplitNo report
Northern Trust and FlexSharesAgainst, against managementSplitFor
Nuveen and TIAAAgainst, against managementSplitFor
Pacific Life fundsAgainst, against managementSplitFor
PGIM and PrudentialAgainst, against managementSplitFor
PIMCOAgainst, against managementSplitNo report
PrincipalAgainst, against managementSplitFor
ProShares and ProFundsAgainst, against managementSplitFor
Russell InvestmentsForSplitFor
SEIForSplitFor
State Street and SPDRForSplitFor
T. Rowe PriceAgainst, against managementSplitFor
ThriventAgainst, against managementSplitFor
VanguardForSplitFor
Victory CapitalAgainst, against managementSplitFor
VirtusAgainst, against managementSplitFor
VoyaAgainst, against managementSplitFor
WisdomTreeForSplitFor

Questions

How many filers reported votes at the Pacira Biosciences, Inc. meeting?
388 Form N-PX filers reported votes at the meeting of 10 Jun 2025. On say-on-pay, 223 of 381 filers that marked the item voted against management (58.5%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Pacira Biosciences, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Pacira Biosciences, Inc. with a meeting date within three days of 10 Jun 2025. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .